According to documents filed by the Hong Kong Stock Exchange on February 8, Wei Meizi, China's leading provider of oral care products, submitted an application for listing on the Hong Kong Stock Exchange on February 8, with co-sponsors AgBank International and BNP Paribas.

Wei Meizi is mainly engaged in the development and sales of a diversified oral care product portfolio covering four major oral care product categories (namely, adult basic oral care, children's basic oral care, electric oral care and professional oral care). Has oral care brand "Shu Ke", children's oral care brand "Shu Ke Baby". In recent years, Weimeizi has successfully built the Shuke brand into a high-profile oral care brand in China.

According to Frost Sullivan, Weimeizi ranks fourth in China's oral care market with 5.3% of the market share in terms of retail sales of all oral care products in 2020. Weimeizi is also the largest provider of children's oral care products in China, with a market share of 20.4%. In addition, Weimeizi ranks fourth in China's electric oral care market with 4.3% of the market share in terms of retail sales in 2020.

In the context of the significant impact of COVID-19 's epidemic on the global economy, Wei Meizi has achieved steady growth in business performance through diversified product strategies and simultaneous improvement of online channels. According to the prospectus, Weimeizi's adjusted net profit increased from 48.193 million yuan in 2019 to 152 million yuan in 2020, and from 82.155 million yuan in the first nine months of 2020 to 129 million yuan in the first nine months of 2021. Strong profitability growth.